Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC) Meeting Abstract

  

Authors:	Galsky, M. D.; Harshman, L. C.; Crabb, S. J.; Wong, Y. N.; Yu, E. Y.; Chowdhury, S.; Powles, T.; Pal, S. K.; Moshier, E. L.; Ladoire, S.; Hussain, S. A.; Agarwal, N.; Vaishampayan, U. N.; Recine, F.; Berthold, D.; Necchi, A.; Theodore, C.; Milowsky, M. I.; Bellmunt, J.; Rosenberg, J. E.
Abstract Title:	Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC)
Meeting Title:	50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	32
Issue:	15 Suppl.
Meeting Dates:	2014 May 30-Jun 3
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2014-05-20
Language:	English
ACCESSION:	WOS:000358613203317
PROVIDER:	wos
DOI:	10.1200/jco.2014.32.15_suppl.4512
Notes:	Meeting Abstract: 4512 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/80905